Pricing
  1. US-listed companies
  2. BIOLASE, INC
  3. Financials
  4. Total liabilities

BIOLASE, INC【BIOLQ】

Market cap
$36.6
P/E ratio
SummaryFinancials
Period EndTotal liabilities (Million USD)YoY (%)
Dec 31, 202333-0.46%
Dec 31, 202233+10.71%
Dec 31, 202130-2.97%
Dec 31, 202031+12.70%
Dec 31, 201928+0.28%
Dec 31, 201827+99.85%
Dec 31, 201714-30.95%
Dec 31, 201620+14.72%
Dec 31, 201517-0.12%
Dec 31, 201417-23.10%
Dec 31, 201323+11.78%
Dec 31, 201220+17.06%
Dec 31, 201117

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)